Based on what’s publicly available, investors may not be seeing the full picture. I’m connecting the dots from available information, and things don’t seem to fully add up.
I’m not making any accusations toward management. These observations are based on publicly available records and may warrant further clarification by the company. It’s possible some of this was not viewed by management as relevant, but it appears to be.
OTC Pink Basic Disclosure Guidelines (Item 10) require the disclosure of all material debt, including judgments, promissory notes, and bank loans.
Risk— Management disclosed approximately $169k in M&T debt in Note 6, while public records suggest total obligations may be closer to $469,829.52. Given the company’s limited liquidity, this amount could represent a material liability. If not fully disclosed, this may result in an understatement of liabilities and a potentially incomplete presentation of the balance sheet.
If these obligations are not fully reflected in the Balance Sheet or Notes to Financial Statements, the financials may not present a complete picture.
Undisclosed Legal Matters (Case CV-2019-008314)
A $50,000 dispute involving CEO David Dalton and Wellness RX Corp appears to be a relevant disclosure point.
Under OTC Guidelines, companies are expected to disclose legal proceedings involving officers or directors within the past five years if material to evaluating their integrity.
Since this case was active in 2018/2019 and settled in 2020, it fell within the five-year window when UNVC filed its catch-up reports in 2021. This may be considered material information from an investor’s perspective .
Filings state: “The Company has no subsidiaries, parents, or affiliated companies.” However, Univec Conglomerate Inc. was renamed back to Univec Inc. in 2021, and both share the same Company Number (627047), which appears in the filings. This may warrant clarification, for the forfeited MD entity (F07298094)
OTC Markets also requires a clear Corporate History and Description of Business. Omission of related entities could raise questions about completeness of disclosure.
By not listing the settlement, active judgments, or the forfeited entity (F07298094), it may appear that certain liabilities were not fully reflected at the time of certification.
In the March 1 annual report, the company states it did not generate profits for the year ended December 31, 2025, and that it has no subsidiaries.
Ultimately, OTCM’s compliance team will make the final determination.
PL
I’m not making any accusations toward management. These observations are based on publicly available records and may warrant further clarification by the company. It’s possible some of this was not viewed by management as relevant, but it appears to be.
OTC Pink Basic Disclosure Guidelines (Item 10) require the disclosure of all material debt, including judgments, promissory notes, and bank loans.
Risk— Management disclosed approximately $169k in M&T debt in Note 6, while public records suggest total obligations may be closer to $469,829.52. Given the company’s limited liquidity, this amount could represent a material liability. If not fully disclosed, this may result in an understatement of liabilities and a potentially incomplete presentation of the balance sheet.
If these obligations are not fully reflected in the Balance Sheet or Notes to Financial Statements, the financials may not present a complete picture.
Undisclosed Legal Matters (Case CV-2019-008314)
A $50,000 dispute involving CEO David Dalton and Wellness RX Corp appears to be a relevant disclosure point.
Under OTC Guidelines, companies are expected to disclose legal proceedings involving officers or directors within the past five years if material to evaluating their integrity.
Since this case was active in 2018/2019 and settled in 2020, it fell within the five-year window when UNVC filed its catch-up reports in 2021. This may be considered material information from an investor’s perspective .
Filings state: “The Company has no subsidiaries, parents, or affiliated companies.” However, Univec Conglomerate Inc. was renamed back to Univec Inc. in 2021, and both share the same Company Number (627047), which appears in the filings. This may warrant clarification, for the forfeited MD entity (F07298094)
OTC Markets also requires a clear Corporate History and Description of Business. Omission of related entities could raise questions about completeness of disclosure.
By not listing the settlement, active judgments, or the forfeited entity (F07298094), it may appear that certain liabilities were not fully reflected at the time of certification.
In the March 1 annual report, the company states it did not generate profits for the year ended December 31, 2025, and that it has no subsidiaries.
Ultimately, OTCM’s compliance team will make the final determination.
PL
2
